Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Prevention and Treatment of Cancer-Related Infections JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK Baden, L. R., Bensinger, W., Angarone, M., Casper, C., Dubberke, E. R., Freifeld, A. G., Garzon, R., Greene, J. N., Greer, J. P., Ito, J. I., Karp, J. E., Kaul, D. R., King, E., Mackler, E., Marr, K. A., Montoya, J. G., Morris-Engemann, A., Pappas, P. G., Rolston, K., Segal, B., Seo, S. K., Swaminathan, S., Naganuma, M., Shead, D. A. 2012; 10 (11): 1412-1445

Abstract

Patients with cancer are at increased risk for developing infectious complications during the course of their disease and treatment. The following sections of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections provide an overview of the risk factors for infectious complications, recommendations for infectious risk categorization, and strategies for prevention of infections in high-risk patient populations with cancer. Individualized risk evaluation for infections and incorporation of preventative measures are essential components of the overall spectrum of cancer care, and may contribute to optimizing treatment outcomes for patients.

View details for Web of Science ID 000310822900011

View details for PubMedID 23138169